FDA Cosmetics Office Shifts Focus As Bioterrorism, BSE Take Priority

FDA initiatives to counter potential bioterrorism through agency-regulated products - including cosmetics - have prompted a priority shift for the agency's Office of Cosmetics & Colors, Division of Science and Applied Technology Director Adele Dennis, PhD, said